Tuesday, February 21, 2017 10:39:49 AM
On October 13, 2015 I posted (post #8555) on this board the following:
After that post I sent Tim Young an email with this idea suggesting that HYSR could use such a technology as either a functioning fuel cell or a Hydrogen gas producer depending on how one implemented the electrodes. He wrote me back saying he would pass it onto their researchers (Tim is not a scientist). What is reported in the news release is precisely what I suggested, that is, if the membrane is graphene or any other semi-permeable membrane material that selectively passes Hydrogen ion, which it must do.
I have never thought that the nanoparticles alone would be able to generate sufficient H2 as the voltage required is just too high for a molecular catalyst to sustain. The news release seems to be saying via the statement that they will still work on the nanoparticles, meaning that they don't work well enough to commercialize yet.
It is clear that this is a shift to a technology that can be commercialized. It actually can be used for either H2 or FCEL with very little implementation difference and therefore could produce "revenue" on down the road. I hope that is what this news release is saying.
Recent HYSR News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:05:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/24/2024 08:44:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 08:05:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/03/2024 08:06:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 08:05:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/21/2024 07:32:27 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/15/2024 09:01:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2024 09:31:40 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/02/2024 05:15:09 AM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 01/25/2024 09:40:59 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/24/2024 09:32:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 08:28:16 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/29/2023 09:03:04 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/29/2023 08:33:39 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM